Startups
Roundups

Meet the University City Science Center’s 27-person board

Helen Giles-Gee, University of the Sciences' current (and first female) president, was recently appointed to the board of the University City Science Center.

Helen Giles-Gee, the first female president of University of the Sciences, was recently appointed to the board of the University City Science Center. Photo by Clem Murray for the Inquirer.

Helen Giles-Gee, University of the Sciences‘ current (and first female) president, was recently appointed to the board of the University City Science Centeraccording to a release.

It’s a 27-person board with big local names like Penn‘s executive vice president Craig Carnaroli, WHYY CEO Bill Marrazzo and Phoenix IP Ventures managing partner Osagie O. Imasogie. The board, which guides the operations and strategic plan for the Science Center, is usually elected by the Science Center’s shareholders to three-year terms that can be renewed infinitely, but Giles-Gee was appointed by the board to fill a vacant spot on an interim basis, said Science Center spokeswoman Jeanne Mell.

The shareholders are 31 local universities, colleges and research institutions. The Science Center’s shareholders’ main role is to elect the Board of Directors, Mell said.

The board doesn’t have any specific requirements on representation across industries but it has a limit of 29 members and has members from the entire Greater Philadelphia region, Mell said.

Find a full list of the board of directors here.

Companies: University City Science Center / University of the Sciences
Engagement

Join the conversation!

Find news, events, jobs and people who share your interests on Technical.ly's open community Slack

Trending

Philly daily roundup: Jason Bannon leaves Ben Franklin; $26M for narcolepsy treatment; Philly Tech Calendar turns one

Philly daily roundup: Closed hospital into tech hub; Pew State of the City; PHL Open for Business

Philly daily roundup: A better coffee supply chain; Philly Tech Week returns; Apply to Pennovation Accelerator

A biotech hub is rising at Philadelphia’s shuttered Hahnemann Hospital campus

Technically Media